Yao Dong

Wecare Probiotics R&D Centers
Suzhou, 215200, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Weizmannia coagulans BC99 Ameliorates Obesity and Associated Inflammation by Remodeling the Gut Microbiota and Regulating Lysophosphatidylcholine and Conjugated Bile Acid Metabolism.

Weizmannia coagulans BC99 Ameliorates Obesity and Associated Inflammation by Remodeling the Gut Microbiota and Regulating Lysophosphatidylcholine and Conjugated Bile Acid Metabolism.

Journal: Metabolites

Published: March 01, 2026

Information gain-based molecular ecological network reveals core microbial taxa involved in gastrointestinal recovery following H. pylori infection and intervention with Weizmannia coagulans BC99 in mice.

Information gain-based molecular ecological network reveals core microbial taxa involved in gastrointestinal recovery following H. pylori infection and intervention with Weizmannia coagulans BC99 in mice.

Journal: Microbial pathogenesis

Published: December 05, 2025

Bifidobacterium Breve BBr60 Improves Obesity Via the Gut Microbiota-Short-Chain Fatty Acid-IL-27/GLP-1 Axis: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial.

Bifidobacterium Breve BBr60 Improves Obesity Via the Gut Microbiota-Short-Chain Fatty Acid-IL-27/GLP-1 Axis: Evidence from a Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Probiotics and antimicrobial proteins

Published: September 10, 2025

Strain-Specific Safety Evaluation of Akkermansia muciniphila Akk11: Comprehensive Genotypic, Phenotypic, and Toxicological Assessment.

Strain-Specific Safety Evaluation of Akkermansia muciniphila Akk11: Comprehensive Genotypic, Phenotypic, and Toxicological Assessment.

Journal: Food science & nutrition

Published: August 31, 2025

High-potency multi-strain probiotic formulations for safety and improvement of gastrointestinal function and intestinal health: a randomized controlled clinical trial.

High-potency multi-strain probiotic formulations for safety and improvement of gastrointestinal function and intestinal health: a randomized controlled clinical trial.

Journal: Frontiers in nutrition

Published: August 31, 2025

Safety and immune-regulating effects of Limosilactobacillus reuteri LR08: Preclinical and clinical evidence from a randomized controlled trial.

Safety and immune-regulating effects of Limosilactobacillus reuteri LR08: Preclinical and clinical evidence from a randomized controlled trial.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: August 29, 2025

Effects of Two Compound Probiotic Formulations on Gastrointestinal Symptoms and Gut Microbiota: A 4-Week Randomized, Double-Blind Intervention Trial.

Effects of Two Compound Probiotic Formulations on Gastrointestinal Symptoms and Gut Microbiota: A 4-Week Randomized, Double-Blind Intervention Trial.

Journal: Nutrients

Published: August 02, 2025

Weizmannia coagulans BC179 Alleviates Post-Alcohol Discomfort May via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind, Placebo-Controlled Trial.

Weizmannia coagulans BC179 Alleviates Post-Alcohol Discomfort May via Taurine-Related Metabolism and Antioxidant Regulation: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Antioxidants (Basel, Switzerland)

Published: July 21, 2025

Weizmannia coagulans BC99 alleviates hyperuricemia by restoring liver-kidney-gut axis dysfunction caused by hyperuricemia.

Weizmannia coagulans BC99 alleviates hyperuricemia by restoring liver-kidney-gut axis dysfunction caused by hyperuricemia.

Journal: Food & function

Published: July 08, 2025

Weizmannia coagulans BC99 regulates oxidative stress and serum metabolic pathways to improve allergic rhinitis: a randomized, double-blind, placebo-controlled trial.

Weizmannia coagulans BC99 regulates oxidative stress and serum metabolic pathways to improve allergic rhinitis: a randomized, double-blind, placebo-controlled trial.

Journal: Frontiers in immunology

Published: June 26, 2025

Weizmannia Coagulans BC99 Prevents Loperamide-Induced Functional Constipation in Mice Through Increased Intestinal Peristalsis and Modulation of Gut Microbiota Dysbiosis.

Weizmannia Coagulans BC99 Prevents Loperamide-Induced Functional Constipation in Mice Through Increased Intestinal Peristalsis and Modulation of Gut Microbiota Dysbiosis.

Journal: Nutrients

Published: March 28, 2025

Lactiplantibacillus plantarum Lp05 protects against ethanol-induced liver injury in zebrafish through metabolic and microbiota modulation.

Lactiplantibacillus plantarum Lp05 protects against ethanol-induced liver injury in zebrafish through metabolic and microbiota modulation.

Journal: Scientific reports

Published: March 20, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026